Searched for
NORETHINDRONE
Lupin launches generic contraceptive drug in USDrug maker Lupin On Thursday said it has launched Merzee capsules, a medication used to prevent pregnancy, in the US market. The Mumbai-bas...- Lupin recalls around 5.61 lakh pouches of birth control pills in the US marketThe product is used to prevent pregnancy. It is manufactured in India and then supplied in the US market by Lupin Pharmaceuticals Inc, the ...
- Glenmark Pharmaceuticals gets USFDA nod for contraceptive drugsThe company's current portfolio consists of 137 products authorised for distribution at the US marketplace and 61 Abbreviated New Drug Appl...
- Lupin initiates recall of tablet Mibelas 24 Fe from US marketAccording to a notification issued by the US Food and Drug Administration (USFDA), as many as 24,652 tablets are being recalled under 'clas...
- Glenmark gets USFDA tentative nod for oral contraceptivesAccording to IMS Health sales data for the 12 months to February 2016, Lo Loestrin Fe achieved annual sales of around $432.2 million, Glenm...
- Lupin launches generic Femhrt tablets in USDrug firm Lupin has launched its generic norethindrone acetate and ethinyl estradiol tablets used for the prevention of postmenopausal oste...
- Glenmark Pharma gets USFDA nod for two generic drugsQuoting IMS data, Glenmark Pharma said the approved product has an estimated market size of $74.1 million for the 12 months ended November ...
- Aurobindo Pharma receives USFDA nod for generic drugThe company's product is generic version of Duramed Pharmaceuticals Aygestin tablets in the same strength, Aurobindo Pharma said.
- Glenmark gets USFDA nod for post-menopause osteoporosis drugThe approval for sale of Norethindrone Acetate and Ethinyl Estradiol tablets was given to Glenmark Generics Inc USA, a subsidiary of Glenma...
- Lupin gains on FDA approval for oral contraceptiveShares of Lupin gained momentum in weak market after it received US FDA approval for oral contraceptive tablets.
- Glenmark Pharmaceuticals gets USFDA approval for oral contraceptivesGlenmark Pharmaceuticals today said it has received final approval from the US health regulator for its generic two oral contraceptives tab...
- Lupin eyes $150 mn from oral contraceptives in US by FY14Drug firm Lupin is expecting revenues of up to USD 150 million (over Rs 780 crore) from its oral contraceptive (OC) segment in the US marke...
- Lupin gets USFDA nod for generic oral contraceptive tabletsLupin has received approval from USFDA to sell 'LoSeasonique' tablets, an oral contraceptive drug, in the American mkt.
- Lupin gains on USFDA nod; Goldman recommends 'Buy'Shares of drugmaker Lupin rose nearly 2 percent after it received the US regulatory approval on Tuesday to launch oral contraceptive
- Lupin gets FDA approval for oral contraceptiveLPI has been granted final approval by the US FDA for its ANDA to market a generic version of Watson's NOR-QD® tablets.
- Glenmark gets USFDA nod for oral contraceptive; stock upGlenmark Pharmaceuticals’ subsidiary Glenmark Generics has received final approval from the USFDA for Norethindrone and Ethinyl Estradiol, ...
- Glenmark unit bags USFDA nod for generic contraceptive drugGlenmark Pharmaceuticals today said it has received health regulator's nod to market and distribute generic contraceptive pills, Norethindr...
Load More- Lupin initiates recall of tablet Mibelas 24 Fe from US market
